Otsuka Holdings
4578.T
#667
Rank
โ‚น3.576 T
Marketcap
โ‚น6,792
Share price
-1.49%
Change (1 day)
78.47%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น338.02. In 2025 the company made an earnings per share (EPS) of โ‚น420.27 an increase over its 2024 EPS that were of โ‚น387.35.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-26.77%
2025โ‚น420.278.5%
2024โ‚น387.35153.9%
2023โ‚น152.56-15.71%
2022โ‚น180.99-6.18%
2021โ‚น192.91-24.1%
2020โ‚น254.1722.95%
2019โ‚น206.7256.13%
2018โ‚น132.40-25.11%
2017โ‚น176.8125.99%
2016โ‚น140.34-6.37%
2015โ‚น149.90
2014N/A-100%
2013โ‚น225.8418.06%
2012โ‚น191.281.01%
2011โ‚น189.3729.07%
2010โ‚น146.72-94.47%
2009โ‚น2,652